Versartis' Series A Round

Versartis raised a round of funding on June 18, 2009. Investors include Medicxi Ventures.

Versartis is a biotechnology company developing therapeutics for the treatment of endocrine disorders. The company's lead product candidate is VRS-317, a once monthly form of human growth hormone. Ver…

Articles about Versartis' Series A Round: